Dimension Therapeutics competitive analysis

Latest publications and patents of Dimension Therapeutics New

Explore the latest publications and patents granted to Dimension Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 26, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Dimension Therapeutics

Nov 27, 2024Use Of Tonicifying Agents To Enhance Recombinant Adeno-Associated Virus YieldGranted And Under Opposition

Explore Dimension Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 27, 2024Use Of Tonicifying Agents To Enhance Recombinant Adeno-Associated Virus Yield1

Latest PTAB cases involving Dimension Therapeutics

Discover the latest PTAB cases involving Dimension Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Dimension Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
DIMENSION THERAPEUTICS - 1 - - Non-Active
STRAWMAN331 - - - Highly Aggressive